Gamot API is the holding company of Sekhmet Pharmaventures Pvt. Ltd. Asian private equity major PAG has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, along with Indian private equity firms, CX Partners and Samara Capital, to buy stakes in fast-growing Indian pharma companies. The Indian subsidiary of Gamot API is known as Sekhmet Pharmaventures Pvt. Ltd.
Sekhmet Pharmaventures has acquired major stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020. Subsequently, Sekhmet Pharmaventures acquired major stake in Optimus Drugs Group of Companies in May 2022. The Company plans to invest in multiple manufacturing facilities dedicated to Active Pharmaceutical Ingredients and formulations, as India is expected to become an important part of the global supply chain, amid changing geopolitical dynamics.
PAG is one of Asia’s leading investment firms, having a world-class platform and an unparalleled network of local, experienced investment professionals. PAG manages US$45 billion in capital across strategies including private equity, real estate and absolute returns. Some of PAG’s past investments include Sinopharm, Alphamab Oncology, Cushman & Wakefield, Universal Studios, Japan, Hisun Bioray and Tencent Music Entertainment.
DATE AND TIME:
- Date: 15th Nov
- Time: 9 AM – 1 PM
- Venue: M/s Optimus Drugs (R&D), Plot No 73/Β & 73/Β/2, ΕPIP, IDA, Pashamylaram, Patancheru, Hyderabad – 502 307.
- Send your CV: vyshali.tokala@sekhmetpharma.com
JOB DETAILS:
- Positions: Trainee / Executive (0–2 years)
- Qualification: B.Sc / Diploma in Chemistry or B.Tech in Chemical Engineering
- Location: Hyderabad (Units at Dothigudem & Ramalingampally)
Requirement:
- Experience in pharmaceutical/API production.
- Basic understanding of GMP & production equipment.
For More JOB Updates Join Our Whatsapp Group Click Here
